Swati Piramal
Apr 11, 2012 at 19:29 | Source: CNBC-TV18
Apr 05, 2012 at 09:27 | Source:
Jan 31, 2012 at 13:45 | Source: CNBC-TV18
Jan 31, 2012 at 12:57 | Source:
Jun 22, 2010 at 12:24 | Source: CNBC-TV18
May 26, 2010 at 21:48 | Source: CNBC-TV18
Videos »
Photos »
/ 
News across the web »
May 17, 2012 at 07:36 | Source: Economic Times
May 15, 2012 at 11:06 | Source: Economic Times
Apr 30, 2012 at 18:07 | Source: Assocham
Apr 17, 2012 at 16:21 | Source: Business Standard
Apr 11, 2012 at 20:51 | Source: Business Today
Interact & exchange stock tips & market info »
Related News »
The new drug will be the second molecule in Piramal's oncology pipeline to enter phase II trials. The first molecule P276 is in phase II/III trials for multiple indications of cancer. Dr Swati Piramal, director, said, “We are extremely pleased with the ...
May 22, 2012 at 07:17 | Source: pharmabiz.com
"We are extremely pleased with the results of the P1446A -05 and are committed to moving the molecule further in clinical development for the treatment of cancer," Piramal Healthcare Director Swati Piramal said in a statement. The data of the Phase-I ...
May 22, 2012 at 11:49 | Source: zeenews.india.com
as the ICRS membership includes the most renowned international orthopaedic surgeons and researchers in this growing clinical field," remarked Dr. Swati A. Piramal, Director, Piramal Healthcare Limited, "Our Symposium at ICRS represents the next ...
May 14, 2012 at 04:35 | Source: Newsblaze.com
Piramal Healthcare Bio-Orthopaedics ... international orthopaedic surgeons and researchers in this growing clinical field," remarked Dr. Swati A. Piramal, Director, Piramal Healthcare Limited, "Our Symposium at ICRS represents the next step ...
May 14, 2012 at 06:22 | Source: Yahoo Finance
Drug discovery will, however, continue to remain a passion for Piramal and his doctor-turned-scientist wife, Swati. And, the group will invest up to $200 million in new molecules and formulations. But, it cannot be devoid of commercial realities.
May 20, 2012 at 17:21 | Source: Business Standard
Piramal Healthcare presents phase III clinical trial results of BST-CarGel at World Congress of ICRS
Piramal Healthcare Bio-Orthopaedics ... international orthopaedic surgeons and researchers in this growing clinical field,” remarked Dr Swati A Piramal, director, Piramal Healthcare Limited, “Our Symposium at ICRS represents the next step in our ...
May 14, 2012 at 10:19 | Source: pharmabiz.com